Cargando…
Randomised clinical non-inferiority trial comparing two formulations of desoxycortone pivalate for the treatment of canine primary hypoadrenocorticism
BACKGROUND: This clinical trial compared two formulations of desoxycortone pivalate (DOCP) for treating the mineralocorticoid deficit in dogs with primary hypoadrenocorticism (PH). METHODS: At veterinary clinics in the USA and France, dogs with PH (n=152) were randomised (3:1) to receive approximate...
Autores principales: | Farr, Hayley, Mason, Beasley L, Longhofer, Susan L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456700/ https://www.ncbi.nlm.nih.gov/pubmed/31974265 http://dx.doi.org/10.1136/vr.105328 |
Ejemplares similares
-
Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism
por: Jaffey, J.A., et al.
Publicado: (2017) -
Canine behaviour problems in Brazil: a review of 180 referral cases
por: Ramos, Daniela, et al.
Publicado: (2020) -
Evaluating the use of cytosine arabinoside for treatment for recurrent canine steroid-responsive meningitis-arteritis
por: Günther, Christian, et al.
Publicado: (2020) -
Controlled field study evaluating the clinical efficacy of a topical formulation containing emodepside and praziquantel in the treatment of natural cat aelurostrongylosis
por: Crisi, Paolo Emidio, et al.
Publicado: (2020) -
Clinical features and long‐term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone
por: Sieber‐Ruckstuhl, Nadja S., et al.
Publicado: (2023)